Sun Pharma ends deal for taking over Taro Pharmaceutical

Reuters : Sat Feb 09 2013, 19:17 hrs

Ads by Google

Top Stories

Sun Pharmaceutical Industries Ltd ended its agreement to takeover Israeli unit Taro Pharmaceutical Industries Ltd.

The companies decided that ending the deal was in the best interest of their shareholders, Sun Pharma and Taro said in a joint filing.

Sun Pharma had last offered $39.50 per share, or about $571 million, for the one-third stake it did not already own in Taro, seemingly winning over the Israeli company's board following a long battle to gain full control of the U.S. listed drugmaker.

Taro shares closed at $50.55 on Thursday on the New York Stock Exchange.

Sun Pharma shares closed at 746.10 rupees on Friday on the National Stock Exchange.

Ads by Google

ALSO READ

Now, 15-year-old girls can buy morning after emergency contraceptive pills in US

US govt sues Novartis for health care fraud

US govt sues Novartis Pharmaceuticals for health care fraud

'New norms won't lead to rise in drug prices for a year'

The product is generic version of Novartis AG's Reclast injection in the same strength. (Reuters)

Dr Reddy's launches generic Zoledronic Acid injection in US

Please read our terms of use before posting comments

TERMS OF USE: The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).